ADAM12: a novel first‐trimester maternal serum marker for Down syndrome
Prenatal Diagnosis2003Vol. 23(13), pp. 1086–1091
Citations Over TimeTop 10% of 2003 papers
Jennie Laigaard, T. L. Sørensen, Camilla Fröhlich, Bent Nørgaard Pedersen, Michael Christiansen, Kirsten Marie Schiøtt, Niels Uldbjerg, Reidar Albrechtsen, Helle V. Clausen, Bent Ottesen, Ulla M. Wewer
Abstract
ADAM12 is a promising marker for Down syndrome.
Related Papers
- → Use of the combined first‐trimester screen result and low PAPP‐A to predict risk of adverse fetal outcomes(2008)70 cited
- → Correlation Between PAPP-A Levels Determined During the First Trimester and Birth Weight at Full-Term(2023)10 cited
- → First‐trimester nuchal translucency and maternal serum free β‐hCG and PAPP‐A can detect triploidy and determine the parental origin(2004)33 cited
- Studies on Protease Activities of the Nemertean Procephalothrix simulus(2008)
- → Faculty Opinions recommendation of The role of ultrasound examination in the first trimester and at 16 weeks' gestation to predict fetal complications in monochorionic diamniotic twin pregnancies.(2008)